Spironolactone After Liver Transplant

NCT02883400 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Transplant, Liver

Interventions

DRUG: Spironolactone

Sponsor

Wake Forest University Health Sciences